Table 1.
Patient demographics
| Patient# | Gender | Age | Diagnosis | Current medications |
|---|---|---|---|---|
| 1 | F | 40 | Adenocarcinoma | Prozac, synthroid, glipizide, actos, Lipitor, wellbutrin, hydrocodone, lorazepam, Maxalt |
| 2 | F | 66 | Endobronchial adenocarcinoma | Advair, albuterol, Triametenane, aspirin |
| 3 | M | 60 | Bronchioloalveolar carcinoma | Albuterol, Lipitor, Flomax, Celexa, Coumadin |
| 4 | M | 70 | Non-small-cell lung cancer | Lisinopril, Prilosec, alprazolam |
| 5 | F | 60 | Squamous cell carcinoma of the lung | Lipitor, effexor, Ambien |
| 6 | M | 79 | Adenosquamous carcinoma | Plavix, Coreg, Renagel, Nephrocaps, insulin, Epogen, Proscar |
| 8 | M | 67 | Adenocarcinoma | Benicar, Rituxan |
| 9 | M | 72 | Adenocarcinoma | Cisplatin |
| 10 | M | 79 | Squamous cell carcinoma | Simvastatin, terazosin, Fluconazole, aspirin, niacin, isosorbide mononitrate, Amlodipine |
| 11 | M | 55 | Melanoma | Allopurinol |
| 12 | F | 60 | Sarcoma | Lipitor, Lisinopril, Trazodone |
| 13 | M | 59 | Squamous cell carcinoma | Aspirin, Colchicine, Lipitor, Lisinopril, Metoprolol |
F = Female; M = male.